SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-254562
Filing Date
2017-08-10
Accepted
2017-08-10 16:41:40
Documents
9
Period of Report
2017-08-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d398744d8k.htm 8-K 37235
2 EX-2.1 d398744dex21.htm EX-2.1 1212350
3 EX-99.1 d398744dex991.htm EX-99.1 36763
4 GRAPHIC g398744g00w79.jpg GRAPHIC 12255
5 GRAPHIC g398744g19r86.jpg GRAPHIC 204127
6 GRAPHIC g398744g21a08.jpg GRAPHIC 694215
7 GRAPHIC g398744g30a53.jpg GRAPHIC 22156
8 GRAPHIC g398744g66r02.jpg GRAPHIC 208851
9 GRAPHIC g398744g73g66.jpg GRAPHIC 59561
  Complete submission text file 0001193125-17-254562.txt   2943064
Mailing Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149
Business Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149 919-576-2306
CEMPRA, INC. (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 262644445 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35405 | Film No.: 171021964
SIC: 2834 Pharmaceutical Preparations